skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: As a followup to my CRJ.TO question (and thx), are you suggesting that Claude's stock price moving forward is limited/tied to the SSO price due to the upcoming acquisition, and to simply steer clear? I was actually unaware of SSO's interest in the company. If so, is there another smaller gold miner worth considering in its place vs FR. Thanks again for the heads up. Ron
Read Answer Asked by Ron on April 29, 2016
Q: I have invested in Sherritt bonds in the past when they came under pressure and made capital gains at maturity. I am looking at the bonds that are due November 15, 2017 with a coupon of 8% and priced at $51.50 per $100.00 plus accrued interest and was wondering what your thoughts would be of purchasing $10,000.00 face value for approximately $5,550.00 and holding till maturity.
Thank you
Read Answer Asked by Isabel on April 29, 2016
Q: I currently have no gold exposure & recent action has certainly caught my attention. What is your opinion on Claude Resources?
I am considering an initial combined purchase of AEM, CRJ, and RIC when/if there is a bit of a consolidation or pullback. What would you suggest as an allocation percentage? I've really appreciated reading your unbiased guidance over the years. Many thx, Ron.
Read Answer Asked by Ron on April 29, 2016
Q: TD Securities has recommended PPY as an action list buy, with a 12 month target price of $10.00. What would be your evaluation of this stock?

Thanks for your help,
Glen
Read Answer Asked by Glen on April 29, 2016
Q: Good Morning Guys, great job, I love the service and have been a customer from your very first day in business. In regards to CSU how closely do you consider technical analysis? I read some info this morning that is somewhat concerning. Long term trendline reversal, 50 day MA crossing below the 200 day, then the 200 day rolling over and going negative. Key support is $428, a break below that could suggest $267. Any thoughts? Thanks
Read Answer Asked by Chris on April 29, 2016
Q: Good morning,
I am attempting to simplify and de-risk my US portfolio. I hold Seaspan (at a small profit) and Ship Finance (at a small loss), although both are net positive due to the generous yields. I am considering eliminating one position, and do not want tax considerations to influence the decision. I would appreciate your advice. Thank you.
Read Answer Asked by Peter on April 29, 2016
Q: Hi Team,
I am willing to take a full position in Endo Pharmaceutical, it seems it has been overly punished by the market due to the similarities with VRX (and similar business model) I suppose.

I see limit downside risk and it is, I think, a potential takeover candidate at the current price level (similar to Concordia).
Earnings are coming soon, so I was thinking to take my first half position before the earnings and the rest of my position after but I am not sure... what is your opinion?

Bye the way, congratulations for the latest improvements on the site!

Michel
Read Answer Asked by Michel on April 29, 2016
Q: Hello again: I meant to include this property in the question I asked earlier this morning, but please feel free to charge me another credit. Northwest healthcare was unloved by most analysts for the last couple of years but they seem to have turned the corner in terms of investor sentiment since the stock price is up $2 on what was a $7.50 stock at its low. Is this kind of increase justified in your opinion and what is your view on its prospects going into the future. I notice that they hold the second highest percentage of their holdings in Brazil (although it is still a distant second to their Cdn. holdings) and could this be a concern given Brazil's current economic malaise? Thanks again, Don
Read Answer Asked by Donald on April 29, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!